Clinical Trial

Chinese EOPD Registry

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the Chinese Early-onst Parkinson's disease Registry (CEOPDR) is to develop a database of persons with early-onset Parkinson's disease (EOPD) in China.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2018-04-24.
Trial Details
NCT Number NCT03508960
Lead Sponsor Xiangya Hospital of Central South University
Conditions Parkinson Disease
Enrollment 3,000 participants
Start Date 2017-02-01
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2018-05-11